1. Home
  2. BAER vs ANVS Comparison

BAER vs ANVS Comparison

Compare BAER & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridger Aerospace Group Holdings Inc.

BAER

Bridger Aerospace Group Holdings Inc.

HOLD

Current Price

$0.51

Market Cap

52.9M

Sector

Finance

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

SELL

Current Price

$1.06

Market Cap

50.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BAER
ANVS
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
50.4M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
BAER
ANVS
Price
$0.51
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$3.67
★ $10.50
AVG Volume (30 Days)
728.8K
★ 780.1K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.15
39.39
EPS
★ N/A
N/A
Revenue
★ $122,830,000.00
N/A
Revenue This Year
$10.91
N/A
Revenue Next Year
$14.97
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 24.56
N/A
52 Week Low
$0.52
$1.01
52 Week High
$3.44
$5.50

Technical Indicators

Market Signals
Indicator
BAER
ANVS
Relative Strength Index (RSI) 21.16 35.15
Support Level N/A $1.04
Resistance Level $2.06 $1.43
Average True Range (ATR) 0.08 0.08
MACD 0.00 -0.00
Stochastic Oscillator 3.83 10.71

Price Performance

Historical Comparison
BAER
ANVS

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: